I agree that this site is using cookies. You can find further informations
here
.
X
Login
My folder (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
Show Desktop-Version
Toggle navigation
D. Ross Camidge
329
results:
Search for persons
X
Format
Online (329)
Mediatypes
Articles (Online) (143)
Bookchapter (Online) (2)
OpenAccess-fulltext (184)
Sorted by: Relevance
Sorted by: Year
?
1
CNS Downstaging: An Emerging Treatment Paradigm for Extensi..:
Langston, Jacob
;
Patil, Tejas
;
Ross Camidge, D.
...
Lung Cancer. 178 (2023) - p. 103-107 , 2023
Link:
https://doi.org/10.1016/..
?
2
Short communication: The activity of brigatinib in patients..:
Stinchcombe, Thomas E.
;
Wang, Xiaofei
;
Doebele, Robert C.
...
Lung Cancer. 165 (2022) - p. 43-48 , 2022
Link:
https://doi.org/10.1016/..
?
3
Veliparib and nivolumab in combination with platinum double..:
Clarke, Jeffrey M.
;
Patel, Jyoti D.
;
Robert, Francisco
...
Lung Cancer. 161 (2021) - p. 180-188 , 2021
Link:
https://doi.org/10.1016/..
?
4
Impact of lorlatinib on patient-reported outcomes in patien..:
Peters, Solange
;
Shaw, Alice T.
;
Besse, Benjamin
...
Lung Cancer. 144 (2020) - p. 10-19 , 2020
Link:
https://doi.org/10.1016/..
?
5
Detection of oligoprogressive disease in oncogene-addicted ..:
Ng, Terry L.
;
Morgan, Rustain L.
;
Patil, Tejas
...
Lung Cancer. 126 (2018) - p. 112-118 , 2018
Link:
https://doi.org/10.1016/..
?
6
Final results of the large-scale multinational trial PROFIL..:
Blackhall, Fiona
;
Ross Camidge, D.
;
Shaw, Alice T.
...
ESMO Open. 2 (2017) 3 - p. e000219 , 2017
Link:
https://doi.org/10.1136/..
?
7
Phase Ib study of the mitochondrial inhibitor ME-344 plus t..:
Diamond, Jennifer R.
;
Goff, Barbara
;
Forster, Martin D.
...
Investigational New Drugs. 35 (2017) 5 - p. 627-633 , 2017
Link:
https://doi.org/10.1007/..
?
8
Correction: Corrigendum: Circulating tumour DNA profiling r..:
Chabon, Jacob J.
;
Simmons, Andrew D.
;
Lovejoy, Alexander F.
...
Nature Communications. 7 (2016) 1 - p. , 2016
Link:
https://doi.org/10.1038/..
?
9
BM-32 * CERITINIB (LDK378) FOR TREATMENT OF PATIENTS WITH A..:
Shaw, A.
;
Mehra, R.
;
Tan, D. S. W.
...
Neuro-Oncology. 16 (2014) suppl 5 - p. v39-v39 , 2014
Link:
https://doi.org/10.1093/..
?
10
PPD01.02 Repotrectinib in Patients With ROS1 Fusion-Positiv..:
Drilon, Alexander
;
Camidge, D. Ross
;
Lin, Jessica J.
...
Journal of Thoracic Oncology. 19 (2024) 7 - p. e4-e5 , 2024
Link:
https://doi.org/10.1016/..
?
11
PP01.58 Real-world Outcomes in Patients With EGFR Wildtype ..:
Girard, Nicolas
;
Xu, Qingqing
;
Camidge, D. Ross
...
Journal of Thoracic Oncology. 19 (2024) 7 - p. e28 , 2024
Link:
https://doi.org/10.1016/..
?
12
L2086F Mutant ROS1-Rearranged NSCLC Resistant to Repotrecti..:
Weber, Urs
;
Davies, Kurtis D.
;
Camidge, D. Ross
JTO Clinical and Research Reports. 5 (2024) 7 - p. 100673 , 2024
Link:
https://doi.org/10.1016/..
?
13
Lung Cancer Oncogene-Directed Therapy, Fertility, and Pregn..:
Simons, Emily
;
Camidge, D. Ross
Journal of Thoracic Oncology. 19 (2024) 6 - p. 866-876 , 2024
Link:
https://doi.org/10.1016/..
?
14
Mobocertinib: Mechanism of action, clinical, and translatio..:
Hanley, Michael J.
;
Camidge, D. Ross
;
Fram, Robert J.
.
Clinical and Translational Science. 17 (2024) 3 - p. , 2024
Link:
https://doi.org/10.1111/..
?
15
PPD01.07 Phase 2 Trial of Mecbotamab Vedotin (BA3011), a CA..:
Rotow, Julia
;
Dy, Grace K.
;
Camidge, D. Ross
Journal of Thoracic Oncology. 19 (2024) 7 - p. e7 , 2024
Link:
https://doi.org/10.1016/..
1-15